Literature DB >> 3315182

Production of factor(s) that render polymorphonuclear leukocytes cytostatic from spleen cells stimulated with a streptococcal preparation, OK-432.

S Kimura1, T Inoue, T Yamashita, Y Midorikawa, S Arai, F Sendo.   

Abstract

We previously reported the augmentation of tumor cytotoxicity of polymorphonuclear leukocytes (PMN) by in vivo administration of a streptococcal preparation, OK-432 (S. Watabe et al., J. Natl. Cancer Inst., 72: 1365-1370, 1984). The present study was undertaken to elucidate the mechanisms of the phenomena. Mouse and rat spleen cells were stimulated in vitro with OK-432. The culture supernatants from the stimulated spleen cells (OK sup) contained factor(s) that rendered mouse and rat PMN cytostatic [neutrophil activating factor (NAF)]. The stimulation of spleen cells with a small dose of OK-432 (0.05 micrograms/ml) resulted in the production of maximum NAF, and NAF was produced soon (12 h) after OK-432 stimulation. NAF was partially inactivated with 60 degrees C 30-min treatment, and completely inactivated with 100 degrees C 10 min. NAF was sensitive to pH 2 treatment. The treatment of PMN with OK sup for 5 min at 37 degrees C was sufficient to induce cytostatic activity of PMN. That OK sup contained gamma-interferon and recombinant gamma-interferon showed NAF activity indicate that gamma-interferon is a NAF in OK sup.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315182

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis.

Authors:  H Fukui; C W Reynolds; B Lenz; M Schneider; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors.

Authors:  P M Guyre; A S Campbell; W D Kniffin; M W Fanger
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).

Authors:  A Araki; T Inoue; S Kimura; S Fukase; F Sendo
Journal:  Jpn J Cancer Res       Date:  1990-01

4.  Cytolytic heterogeneity of polymorphonuclear leukocytes in killing of murine tumor cells.

Authors:  M Yamazaki; M Ikenami; T Sugiyama
Journal:  Jpn J Cancer Res       Date:  1988-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.